Co-Authors
This is a "connection" page, showing publications co-authored by Maria Capobianchi and Vincenzo Puro.
Connection Strength
0.625
-
Impact of Prior Influenza and Pneumoccocal Vaccines on Humoral and Cellular Response to SARS-CoV-2 BNT162b2 Vaccination. Vaccines (Basel). 2021 Jun 08; 9(6).
Score: 0.237
-
Phylogenetic analysis of human coronavirus NL63 circulating in Italy. J Clin Virol. 2008 Sep; 43(1):114-9.
Score: 0.097
-
Coordinate Induction of Humoral and Spike Specific T-Cell Response in a Cohort of Italian Health Care Workers Receiving BNT162b2 mRNA Vaccine. Microorganisms. 2021 Jun 16; 9(6).
Score: 0.059
-
Immunogenicity and safety of BNT162b2 COVID-19 vaccine in a chronic lymphocytic leukaemia patient. J Cell Mol Med. 2021 May 25.
Score: 0.059
-
Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital. Int J Infect Dis. 2021 Apr; 105:532-539.
Score: 0.058
-
COVID-19 disease-Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study. PLoS One. 2020; 15(12):e0244129.
Score: 0.058
-
COVID-19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS-CoV-2. J Med Virol. 2021 03; 93(3):1796-1804.
Score: 0.057